Evaluation of the Efficacy and Safety of Mirtazapine in the Treatment of Uremic Pruritus in Hemodialysis Patients: A Randomized, Double-blind, Placebo-controlled Clinical Trial.

J Res Pharm Pract · 2024 · PMC12105765 · PMID 40432841

Europe PMC DOI

hedged sentence

0.0490

closest p · 1.0× alpha

0.0490

boldest claim

The sentences

approached significanceP = 0.049actually significant

Furthermore, the therapeutic response in the mirtazapine group was significantly higher at week 3 (OR = 5.13, P = 0.005) and approached significance at week 4 (OR = 3.67, P = 0.049).

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.